long intergenic non-protein coding RNA 239Genealiases: C14orf72 · NCRNA00239
Q-omics provides the consensus-scored LINC00239 profile across patient tissues and cancer cell-line models. LINC00239 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC00239 is differentially expressed in 14, with the highest sampling consensus in COAD. Additionally, LINC00239 RNA expression shows 13,853 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KIRC, COAD, and UVM as cancer lineages where LINC00239 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00239 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00239 survival associations across molecular data types. LINC00239 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00239 RNA expression–survival associations across cancer types. High LINC00239 expression shows unfavorable associations in KIRC, UVM, COAD and LGG, but favorable associations in OV and UCEC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC00239 RNA expression.
This table summarizes LINC00239 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00239. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00239 shows higher tumor expression in COAD, STAD, READ, KIRP, UCEC and LIHC. The COAD box plot shows higher LINC00239 RNA expression in tumor versus normal tissue (log2 FC = +1.337, t-test p < 0.001).
This table shows molecular features associated with LINC00239 in patient tissues and cancer cell lines. In patient samples, LINC00239 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
